C.I. Medical Co.,Ltd. (TYO:3540)
Japan
· Delayed Price · Currency is JPY 898.00
-5.00 (-0.55%)
May 23, 2025, 3:30 PM JST
C.I. Medical Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 78,204 | 67,493 | 45,628 | 42,891 | 41,205 | 37,393 | Upgrade
|
| Revenue Growth (YoY) | 67.91% | 47.92% | 6.38% | 4.09% | 10.19% | 30.00% | Upgrade
|
| Cost of Revenue | 52,272 | 46,205 | 33,633 | 31,218 | 29,600 | 26,100 | Upgrade
|
| Gross Profit | 25,932 | 21,288 | 11,995 | 11,673 | 11,605 | 11,293 | Upgrade
|
| Selling, General & Admin | 21,033 | 16,690 | 8,995 | 7,675 | 7,080 | 6,589 | Upgrade
|
| Operating Expenses | 23,136 | 18,793 | 9,004 | 7,681 | 7,081 | 6,590 | Upgrade
|
| Operating Income | 2,796 | 2,495 | 2,991 | 3,992 | 4,524 | 4,703 | Upgrade
|
| Interest Expense | -92 | -61 | -17 | - | - | - | Upgrade
|
| Interest & Investment Income | 46 | 47 | 37 | 31 | 21 | 25 | Upgrade
|
| Earnings From Equity Investments | 111 | 19 | 51 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 4 | -9 | -13 | -15 | 8 | -8 | Upgrade
|
| Other Non Operating Income (Expenses) | 154 | 129 | 80 | 36 | 44 | 46 | Upgrade
|
| EBT Excluding Unusual Items | 3,019 | 2,620 | 3,129 | 4,044 | 4,597 | 4,766 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4,504 | 4,493 | -60 | -37 | -292 | -320 | Upgrade
|
| Gain (Loss) on Sale of Assets | 9 | 12 | - | 8 | 6 | 6 | Upgrade
|
| Asset Writedown | -11,620 | -44 | 164 | -164 | - | - | Upgrade
|
| Other Unusual Items | 12,935 | -4 | -51 | -1 | -27 | -2 | Upgrade
|
| Pretax Income | 8,847 | 7,077 | 3,182 | 3,850 | 4,284 | 4,450 | Upgrade
|
| Income Tax Expense | 1,341 | 777 | 1,084 | 1,326 | 1,464 | 1,530 | Upgrade
|
| Earnings From Continuing Operations | 7,506 | 6,300 | 2,098 | 2,524 | 2,820 | 2,920 | Upgrade
|
| Minority Interest in Earnings | -120 | -34 | -16 | -3 | - | - | Upgrade
|
| Net Income | 7,386 | 6,266 | 2,082 | 2,521 | 2,820 | 2,920 | Upgrade
|
| Net Income to Common | 7,386 | 6,266 | 2,082 | 2,521 | 2,820 | 2,920 | Upgrade
|
| Net Income Growth | 308.52% | 200.96% | -17.41% | -10.60% | -3.43% | 94.02% | Upgrade
|
| Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
| Shares Change (YoY) | 0.01% | 0.01% | - | -0.01% | - | - | Upgrade
|
| EPS (Basic) | 147.72 | 125.32 | 41.64 | 50.43 | 56.40 | 58.40 | Upgrade
|
| EPS (Diluted) | 147.72 | 125.32 | 41.64 | 50.43 | 56.40 | 58.40 | Upgrade
|
| EPS Growth | 308.48% | 200.94% | -17.41% | -10.60% | -3.42% | 94.02% | Upgrade
|
| Free Cash Flow | - | 4,929 | -9,086 | -7,939 | -1,253 | 3,701 | Upgrade
|
| Free Cash Flow Per Share | - | 98.58 | -181.74 | -158.80 | -25.06 | 74.02 | Upgrade
|
| Dividend Per Share | 12.530 | 12.530 | 5.044 | 5.044 | 5.642 | 5.842 | Upgrade
|
| Dividend Growth | 148.41% | 148.41% | - | -10.60% | -3.42% | 93.96% | Upgrade
|
| Gross Margin | 33.16% | 31.54% | 26.29% | 27.21% | 28.16% | 30.20% | Upgrade
|
| Operating Margin | 3.57% | 3.70% | 6.55% | 9.31% | 10.98% | 12.58% | Upgrade
|
| Profit Margin | 9.45% | 9.28% | 4.56% | 5.88% | 6.84% | 7.81% | Upgrade
|
| Free Cash Flow Margin | - | 7.30% | -19.91% | -18.51% | -3.04% | 9.90% | Upgrade
|
| EBITDA | 5,461 | 4,831 | 4,013 | 4,388 | 4,869 | 4,974 | Upgrade
|
| EBITDA Margin | 6.98% | 7.16% | 8.79% | 10.23% | 11.82% | 13.30% | Upgrade
|
| D&A For EBITDA | 2,665 | 2,336 | 1,022 | 396 | 345 | 271 | Upgrade
|
| EBIT | 2,796 | 2,495 | 2,991 | 3,992 | 4,524 | 4,703 | Upgrade
|
| EBIT Margin | 3.57% | 3.70% | 6.55% | 9.31% | 10.98% | 12.58% | Upgrade
|
| Effective Tax Rate | 15.16% | 10.98% | 34.07% | 34.44% | 34.17% | 34.38% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.